FDA extends shelf life of Johnson & Johnson COVID vaccine

A combination of softening demand for COVID vaccines overall and lingering safety concerns about the J&J shot, which was linked to extremely rare blood clots, left nearly half of the 21 million doses the company produced for the U.S. sitting unused, Reuters reported.

The article from the source


Related Articles

Back to top button